Hepatobiliary function assessed by 99mTc-mebrofenin cholescintigraphy in the evaluation of fibrosis in chronic hepatitis: histopathological correlation

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Nuclear medicine communications

• Publication date

  2010-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MNM.0b013e328334bff7PMID 20087241
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Utilization rates, complications and costs of percutaneous liver biopsy: a population‐based study including 4275 biopsies

  2008cited by this paper
• Liver biopsy remains the gold standard for evaluation of chronic hepatitis and fibrosis.

  2007cited by this paper
• The incidence and risks of liver biopsy in non-cirrhotic patients: An evaluation of 3806 biopsies

  2007cited by this paper
• Cholescintigraphic measurement of liver function: how is it different from other methods?

  2006cited by this paper
• Hepatobiliary function assessed by 99mTc-mebrofenin cholescintigraphy in the evaluation of severity of steatosis in a rat model

  2006cited by this paper
• Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy.

  2006cited by this paper
• Nuclear receptor ligands: rational and effective therapy for chronic cholestatic liver disease?

  2005cited by this paper
• Evaluation of Liver Fibrosis: A Concise Review

  2004cited by this paper
• Noninvasive diagnosis of liver cirrhosis using DNA sequencer–based total serum protein glycomics

  2004cited by this paper
• Preoperative assessment of liver function: a comparison of 99mTc‐Mebrofenin scintigraphy with indocyanine green clearance test

  2004cited by this paper
• Prevalence and Characteristics of Pain Induced by Percutaneous Liver Biopsy

  2003cited by this paper
• Comparison of Tc-99m-GSA scintigraphy with hepatic fibrosis and regeneration in patients with hepatectomy

  2003cited by this paper
• Evaluation of hepatic functions and biliary dynamics in patients with liver cirrhosis by quantitative scintigraphy.

  2003cited by this paper
• Hepatitis C infection and the patient with end‐stage renal disease

  2002cited by this paper
• Liver biopsy.

  2001cited by this paper
• Liver biopsy.

  2001cited by this paper
• Natural history of hepatitis C.

  1999cited by this paper
• Hepatobiliary scintigraphy in infancy.

  1998cited by this paper
• Hepatic extraction efficiency of technetium-99m-mebrofenin in the dog with toxic-induced acute liver disease.

  1998cited by this paper
• Natural history of hepatitis C

  1997cited by this paper
• Histological grading and staging of chronic hepatitis.

  1995cited by this paper
• Histopathology of Hepatitis C Virus Infection

  1995cited by this paper
• Histological grading and staging of chronic hepatitis.

  1995cited by this paper
• Improved scintigraphic assessment of severe cholestasis with the hepatic extraction fraction

  1990cited by this paper
• Primary biliary cirrhosis: Tc-99m IDA planar and SPECT scanning.

  1988cited by this paper
• Technetium-99m NGA functional hepatic imaging: preliminary clinical experience.

  1985cited by this paper
• [Quantitative analysis by digital computer with Tc-99m PMT hepatogram in diffuse parenchymal liver diseases].

  1984cited by this paper
• The natural history of hepatitis.

  1969cited by this paper

• Membrane transporters in drug development and as determinants of precision medicine

  2024cites this paper
• Optimised quality control method for determination of the radiochemical purity of [99mTc]Tc-mebrofenin and [99mTc]Tc-etifenin in a clinical context

  2023cites this paper
• Liver Fibrosis Conventional and Molecular Imaging Diagnosis Update

  2019cites this paper
• PET/CT with 18F Fluorocholine as an Imaging Biomarker for Chronic Liver Disease: A Preliminary Radiopathologic Correspondence Study in Patients with Liver Cancer.

  2018cites this paper
• Disease‐Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter Consortium

  2018cites this paper
• Hepatobiliary scintigraphy may improve radioembolization treatment planning in HCC patients

  2017cites this paper
• Effect of Liver Disease on Hepatic Transporter Expression and Function.

  2017cites this paper
• Role of endoscopic papillary balloon dilation in patients with recurrent bile duct stones after endoscopic sphincterotomy

  2015cites this paper
• Preparation, quality control and biological characterization of 99mTc-vincristine

  2015cites this paper
• Technetium-99m labelled red blood cells scintigraphy and not iminodiacetic acid cholescintigraphy facilitates the discrimination of hepatic cirrhosis from fibrosis.

  2015cites this paper